Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 8;13(1):6737.
doi: 10.1038/s41467-022-34441-z.

Structural basis for sequence-independent substrate selection by eukaryotic wobble base tRNA deaminase ADAT2/3

Affiliations

Structural basis for sequence-independent substrate selection by eukaryotic wobble base tRNA deaminase ADAT2/3

Luciano G Dolce et al. Nat Commun. .

Abstract

The essential deamination of adenosine A34 to inosine at the wobble base is the individual tRNA modification with the greatest effects on mRNA decoding, empowering a single tRNA to translate three different codons. To date, many aspects of how eukaryotic deaminases specifically select their multiple substrates remain unclear. Here, using cryo-EM, we present the structure of a eukaryotic ADAT2/3 deaminase bound to a full-length tRNA, revealing that the enzyme distorts the anticodon loop, but in contrast to the bacterial enzymes, selects its substrate via sequence-independent contacts of eukaryote-acquired flexible or intrinsically unfolded motifs distal from the conserved catalytic core. A gating mechanism for substrate entry to the active site is identified. Our multi-step tRNA recognition model yields insights into how RNA editing by A34 deamination evolved, shaped the genetic code, and directly impacts the eukaryotic proteome.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. The structure of TbADAT2/3 heterodimer bound to tRNAThrCGU.
a Schematic representation of the protein subunits: ADAT2 CDA in salmon, ADAT3 N-terminal domain in blue, ADAT3CDA in teal. Portions with traced atomic model as solid colors and non-resolved linkers as dotted lines. Important sequence motifs are annotated at their relative positions. Zn2+ coordinating residues are indicated by yellow triangles, the active-site glutamate / pseudo-active-site valine by a red and gray star, ‘gate’ residues of ADAT2 with a blue triangle. Conserved positive charges of the KR-motif annotated as blue “+“ signs. b Structural alignment of Tb, yeast and mouse ADAT2 and ADAT3 CDA domains and Staphylococcus aureus TadA. The sequences for human (Hs) ADAT2/3 included (MmADAT2/3 PDB: 7NZ7, scTAD2/3 PDB:7BV5, saTadA PDB: 2B3J). Structural elements of Tb are annotated (ADAT2 above, ADAT3 below) with α-helices as cylinders and β-sheets as arrows. Zn2+ coordinating residues are indicated by yellow triangles, the active-site glutamate / pseudo-active-site valine by a red and gray star, ‘gate’ residues of ADAT2 with a blue triangle and the active-site histidine of ADAT3 with a teal triangle. ADAT2C is boxed in blue with annotation of the conserved positive charges of the KR-motif (“+“ signs). Grayed out letters indicate non-resolved loops in our structure and ADAT2C residues not resolved in previous crystal structures. An ADAT3 conserved loop is annotated as a teal box. Other colors and boxes within the alignment represent relative conservation above 70%. c Four views of the final non-b-factor-sharpened cryoSPARC map that was used for modeling (presented at a level of 0.09) with atomic model. Colors as above. d Cartoon model of ADAT2/3 bound to tRNA. Colors as in 1 A. Zn2+ atoms in yellow, tRNA in black with only anticodon loop bases represented as slabs, the reactive C34 nucleotide is annotated as C*. Gray arrows point to the ADAT3 N-terminal domain double linker.
Fig. 2
Fig. 2. The interaction of the tRNA anticodon-stem loop with ADAT2/3.
a The anticodon loop (ACL) bound to TbADAT2/3 (black) is distorted with respect to free tRNA (brown; PDB: 1EHZ) but resembles the ACL bound to bacterial TadA (gray; PDB: 2B3J), all cartoon-stick representation. b A deep cleft in the dimer interface accommodates the ACL. Colors as in Fig. 1, ADAT2/3 model as surface representation, tRNA as cartoon with anticodon loop bases shown. c The deformed ACL bound to the TbADAT2/3, backbone in cartoon and bases in stick representation. d Schematic overview of the anticodon stem loop (ACSL) and its interactions with TbADAT2/3. Zinc coordinating site highlighted in yellow. eg Comparison of the active-site pockets of Tb and MmADAT2/3 and TadA in the same orientation: e TbADAT2/3 with tRNA cytosine-base shown; f apo-MmADAT2/3 (PDB: 7NZ7), with the conserved H298MmADAT3 as the only ADAT3 residue present in the active site; g bacterial SaTadA (PDB: 2B3J) with nebularine bound, with M92SaTadA훃 residue contributed by the second protomer of the homodimer. Residue side chains colored by heteroatom with zinc atoms in yellow.
Fig. 3
Fig. 3. The tRNA anticodon loop passes through a molecular RY-gate in ADAT2.
a Superposition of the tRNA-bound gate in TbADAT2/3 and the apo-gate in MmADAT2/3 (PDB: 7NZ7). The side chain of R159TbADAT2 is represented as flexible due to its poor side chain density. b The corresponding positions in bacteria deaminase TadA, RNA bound versus unbound (PDB: 2B3J and 1WWR, respectively). c Fold change of the observed rate constants of mutants to wild-type (krel = kobs mutant/kobs WT). Graph values calculated from three independent replicates. All mutants are of TbADAT2 co-expressed with TbADAT3. n.d. denotes no detectable activity after 24 h assay incubation. kobs values obtained from single-turnover kinetic assays (n≥3). Source data are provided as a Source Data file.
Fig. 4
Fig. 4. The ADAT2 C-terminal region including the KR-motif.
a The C-terminus of ADAT2 embraces nucleotides 35 and 37 and KR-loop residues (K or R) provide additional contacts with the anticodon-stem loop via phosphate backbone interactions at residues 28–31. A cartoon representation of the ADAT2 C-terminus and tRNA is shown with the final non-b-factor-sharpened cryoSPARC map. Due to the limited resolution, we refrain from showing side chains in the ADAT2C model. b The same region of ScTAD2/3 (PDB: 7BV5), MmADAT2/3 (PDB: 7NZ7), and RNA bound SaTadA (PDB: 2B3J). The flexible unmodeled loop of ScADAT2 is shown as a dotted line.
Fig. 5
Fig. 5. ADAT3 N-terminal domain probes the three-dimensional structure of the tRNA.
a Two views of the ADAT3N fitted in the post-processed EM map, in blue, with ‘A’ and ‘B’ regions as the two contact points of our model with tRNA, as indicated in C. b ADAT3N including linkers (residues 4–172); surface model colored by vacuum electrostatic potential, positive charges in red and negative charges in blue, with D-Arm of tRNA in a black cartoon representation. Residues identified to play a role in tRNA binding are annotated in black, in olive from and in yellow from. (c) Schematic of the tRNA with interaction contacts. Anticodon-stem loop interactions are represented as a summary of the ones indicated in Fig. 2D. The two ADAT3N contact points, ‘A’ and ‘B’ are indicated in blue as above.
Fig. 6
Fig. 6. The hypothetical multi-step tRNA recognition mechanism of ADAT2/3.
a Ligand-free enzyme state: in the free ADAT2/3 heterodimer ADAT2C is disordered and ADAT3N is flexibly linked. b Initial capture: the RNA recognition motifs in ADAT3N and in ADAT2C capture RNA; tRNAs are progressively guided by the extension of favorable interactions towards the anticodon binding cleft; hereby non-tRNA architectures will be rejected. c Anticodon loop insertion into the active site: The anticodon loop enters the active-site cleft through the RY-gate, and ADAT2C folds into the major groove of the anticodon loop to position the ligand for the reaction. d Substrate release: Detachment of the individual RNA-binding motifs initiates tRNA release.

Similar articles

Cited by

References

    1. Motorin Y, Helm M. RNA nucleotide methylation: 2021 update. Wiley Interdiscip. Rev. RNA. 2022;13:e1691. - PubMed
    1. Jonkhout N, et al. The RNA modification landscape in human disease. RNA. 2017;23:1754–1769. - PMC - PubMed
    1. Björk GR, Wikström PM, Byström AS. Prevention of translational frameshifting by the modified nucleoside 1-methylguanosine. Science. 1989;244:986–989. - PubMed
    1. Helm M. Post-transcriptional nucleotide modification and alternative folding of RNA. Nucleic Acids Res. 2006;34:721–733. - PMC - PubMed
    1. Grosjean H, Westhof E. An integrated, structure- and energy-based view of the genetic code. Nucleic Acids Res. 2016;44:8020–8040. - PMC - PubMed

Publication types